SCHEMBL3276466

SCHEMBL3276466

OC(Oc1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.51
CYP2C19 P33261 2/20 0.51
KDM4E B2RXH2 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ALDH1A1 P00352 5/20 0.47
CYP2C9 P11712 2/20 0.47
NR2E1 Q9Y466 5/20 0.46
SLC6A4 P31645 7/20 0.46
SLC6A2 P23975 3/20 0.44
HPGD P15428 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ADRA2A P08913 3/20 0.41
ADRA2C P18825 3/20 0.41
ADRA1A P35348 3/20 0.41
HTR1B P28222 3/20 0.41
ADRA2B P18089 2/20 0.41
ADRA1D P25100 2/20 0.41
ADRA1B P35368 2/20 0.41
HTR1D P28221 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28827105 0.81 KDM4E (0.51) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL3276460 0.78 ALDH1A1 (0.52) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL8547012 0.77 CYP1A2 (0.54) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL27351338 0.77 CYP1A2 (0.54) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL1356985 0.77 CYP1A2 (0.54) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL24372107 0.77 CYP1A2 (0.50) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL5608955 0.77 ALDH1A1 (0.50) CYP1A2CYP2C19MEN1KMT2AALDH1A1
SCHEMBL11577421 0.76 KDM4E (0.52) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL14672489 0.76 CYP1A2 (0.62) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL9950214 0.75 ALDH1A1 (0.62) CYP1A2CYP2C19KMT2AALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696374-B2 Arylalklcarbamate derivatives, preparation method thereof and use of same in therapeutics SANOFI-AVENTIS (FR) 2010-04-13 US claimed